Our findings revealed that both agents individually and synergistically inhibit the activation of Jak2 and subsequent phosphorylation of Stat3, a critical transcription factor involved in promoting cell survival and proliferation in neuroblastoma. The gene discussed is STAT3; the disease is neuroblastoma.